MiMedx Group (MDXG) logo

MiMedx Group (MDXG) stock

Amniotic tissue products , market cap $454M

$3.05
-1.93%

Why is MDXG down?

Down 16% on Nov 2, and still 21% under its Oct 30 close.

  • MiMedx fell 16% that day while medical device stocks rose a median 0.8%: it trailed its group by 17 points.

No SEC filing or news in our sources explains it.

Sources: Price history, Nov 2, 2026

−3Long-term trend below a falling 200-day average, down over one year, down over two years

Tell me next time MDXG moves

Free account, no card. An optional alert when MDXG moves or its score changes.Pro, $1 for a first month. An optional alert when MDXG moves or its score changes.Pro, 7 days free with a card. An optional alert when MDXG moves or its score changes.

Or see it live, free until Tuesday morning. No account.Or see one stock in full, free. No account.
Quality Score
-6
Poor
In its industry
#84of 86
Checks firing
1of 14
Trending down
From 52-week high
-59.0%
under its best in a year

MDXG's Quality Score rose 1 point on Fri, Nov 20, to -6. It had its calmest day in a week.

See MDXG's 14 chart checksSee MDXG's 14 chart checksSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on MDXG

Key facts on MDXG
Since its 2024 highDown 68% profit $42.4M → a $19.2M loss a year
Latest filing8-K, Oct 28 Reported its quarterly results

What's next

Expected to report Wed Feb 24, after the close

After its last 4 reports it closed +1.0% on average, higher 3 of 4 times.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

MDXG catalysts

4 past catalysts since 2018, with sizes and sources, for Pro members.

How MDXG ranks in Medical Devices

MDXG is #84 of 86 by Quality Score.

How MDXG ranks in Medical Devices
RankStockQuality Score
84MiMedx Group (MDXG) logoMDXGMiMedx-6

More in Medical Devices

When does MDXG report earnings, and what happens after?

Expected to report Wed Feb 24, after the close (in 95 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What MDXG reported on Oct 28, 2026

The quarter

The figures are not read from the release yet.

“The year-over-year decline in gross margin was driven primarily by the Medicare reimbursement rules negatively impacting the prices of our Wound products along with unfavorable product mix.”

The filing on EDGAR

Where the sales came from

MDXG gives its mix in its presentation's charts, not in a table we read.

The outlook

The outlook the company gave, by period
MeasureFigure
Full year 2026
Net sales$250M to $260Mcut

Figures as filed (SEC filing, Oct 28)

1 more outlook line, for Pro members.

In the company's words

  • “The Company expects Adjusted EBITDA for the fourth quarter to be sequentially higher than the third quarter.”

From its results filing (SEC filing · Oct 28)

2 more sentences, for Pro members.

The numbers

Market value
$454M
today
Sales
$304M
down 22.8% on the year

Sales grew 11% a year over 5 years, fiscal 2020 to 2025.

Its share count grew 6.7% a year over 5 years.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on MDXG: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 4

-6.4%+8.9%+0.9%+0.5%
Feb 25Apr 29Jul 29Oct 28
ReportedGapReaction5
days
Oct 28, 2026After close-8.3%+0.5%-19.0%
Jul 29, 2026After close-7.8%+0.9%-1.6%
Apr 29, 2026After close-1.1%+8.9%+18.6%
Feb 25, 2026After close-0.8%-6.4%-8.7%

MDXG closed higher after 3 of its last 4 reports.

MDXG sales and profit by year

Sales and profit by year

Sales grew in four of the last seven years, to $419M in 2025. It made a profit in three of the eight years.

MDXG has 1 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on MDXG, and all 14 on every stock.Get in free →See the top 3 →Start Pro

MDXG RSI on Nov 20: 22.0, below its 50-day and 200-day averages

Not scored

RSI 22.0, MACD above signal, below both averages. Not scored.

The deep dive on MDXG

6 more findings on MDXG, each with its source, for Pro members.

MDXG's officers and directors

Officers and directors with a Form 4 in the last 12 months.

2 more officers and directors file at MDXG.

See insider trades by person

Which ETFs hold MDXG?

In ETFs: MDXG is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About MiMedx Group

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

808 employeesMarietta, GAmimedx.com

What MiMedx Group says it competes with

“Due to lower barriers to entry in the Section 361 HCT/P regulated market, competition is intense in the skin substitute market, particularly among human-derived products and subject to new entrants and evolving market dynamics.”

From its annual report, SEC filing · Feb 25, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on MDXG and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn MDXG's score around: 7 things
  • 3 more filings explained, a plain line each
  • 3 more things pulling MDXG's score down

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: MDXG's Quality Score is -6 (Poor), #84 of 86 in Medical Devices.

What does MDXG's Quality Score say?

MDXG scores -6 today, which Breakaway calls Poor. It is #84 of 86 in Medical Devices by Quality Score, with 1 of 14 chart checks firing. Down 16% on Nov 2, and still 21% under its Oct 30 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is MDXG's Quality Score?

MDXG scores -6 today, which Breakaway calls Poor (below zero). That is #84 of 86 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MDXG's -6.

When does MDXG report earnings?

Expected to report Wed Feb 24, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. MDXG closed higher after 3 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.